The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice

• Ngā kaituhi matua: Tingting Wu (Author), Yuan Xie (Author), Jing Huang (Author), Ping Li (Author), Xuliang Wang (Author), Yaoyao Yan (Author), Tianhe Xia (Author), Lei Li (Author), Feng Zhu (Author), Hao Li (Author), Rongzhou Wu (Author)
• Hōputu: Pukapuka
• I whakaputaina: Hindawi Limited, 2017-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Bone marrow-derived mesenchymal stem cells (BMSCs) have recently been introduced to treat cardiovascular diseases, such as myocardial infarction and dilated cardiomyopathy. Nevertheless, there are few researches focused on the application of BMSCs in treating viral myocarditis, not to mention its op...